The 17th Golden Helix Pharmacogenomics Day was successfully organized in Rotterdam, the Netherlands May 27th, 2016 by the Golden Helix Foundation and the Erasmus University Medical Center. Overall, the conference was attended by 164 participants from over 10 countries from Europe and the United States and was under the auspices of several national and international organizations, such as the Dutch Royal Pharmacists Association, the Genomic Medicine Alliance, the International Federation of Clinical Chemistry, and others.
Several members of the UPGx Consortium were at the meeting and contributed to the success of the meeting. The UPGx coordinator, Prof. Henk-Jan Guchelaar (Leiden University Medical Center, Leiden, the Netherlands) gave an overview of the U-PGx project and Prof. Matthias Schwabb (Margarete Fisher Bosch Institute, Stuttgart, Germany) presented the latest developments about CYP2D6-guided tamoxifen treatment. Also, Prof. Magnus Ingelman-Sundberg (Karolinska Institutet, Stockholm, Sweden) talked about sequencing of rare variants of pharmacogenomics interest, Prof. George P. Patrinos (University of Patras, Greece) gave an update on the use of whole genome sequencing in pharmacogenomics, Dr. Vera Deneer (KNMP Pharmacogenomics Working Group, den Haag, the Netherlands) who talked about evidence-based dosing based on genotype, and Prof. Jesse Swen (Leiden University Medical Center, Leiden, the Netherlands), who chaired Session III, about dosing guidelines in drug labels, where the experience from the Dutch Pharmacogenomics Working Party and the European Medicines Agency was presented. The meeting was also attended by Dr. Cristina Lucía Dávila Fajardo (Granada, Spain), who will be chairing the Organizing Committee of the upcoming UPGx Pharmacogenomics Day in Granada, Spain, December 1st, 2016.